Nouri Alaleh

SEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

SEC source: 0001628280-24-001196 · wk-form4_1705011139.xml · derivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,697

Underlying: Common Stock · 16,000 shares

Expires 2029-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F4 · derivative.exercise_date: The Stock option was granted on December 12, 2019 and vested over a four year period.

SEC source: 0001628280-24-001196 · wk-form4_1705011139.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,351

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.95 to $45.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-001196 · wk-form4_1705011139.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,351

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2 · balance_after: Includes 418 shares acquired on May 12, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · derivative · entry 6

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,697

Underlying: Common Stock · 11,796 shares

Expires 2029-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F4 · derivative.exercise_date: The Stock Option was granted on December 12, 2019 and vested over a four year period

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · nonDerivative · entry 4

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,933

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $43.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · nonDerivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · derivative · entry 5

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,493

Underlying: Common Stock · 3,204 shares

Expires 2029-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F4 · derivative.exercise_date: The Stock Option was granted on December 12, 2019 and vested over a four year period

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,933

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $42.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-23-041703 · wk-form4_1702682929.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

SEC source: 0001628280-23-041179 · wk-form4_1702083941.xml · derivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,452

Underlying: Common Stock · 6,096 shares

Expires 2028-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F3 · derivative.exercise_date: The Stock Option was granted on September 28, 2018 and vested over a four year period.

SEC source: 0001628280-23-041179 · wk-form4_1702083941.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,933

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $39.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-23-041179 · wk-form4_1702083941.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

SEC source: 0001628280-23-026243 · wk-form4_1690833941.xml · derivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,549

Underlying: Common Stock · 7,903 shares

Expires 2028-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F3 · derivative.exercise_date: The Stock Option was granted on September 28, 2018 and vested over a four year period.

SEC source: 0001628280-23-026243 · wk-form4_1690833941.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,933

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.9500 to $40.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-23-026243 · wk-form4_1690833941.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,836

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

SEC source: 0001628280-23-017281 · wf-form4_168375128984925.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,452

Underlying: Common Stock · 12,123 shares

Expires 2028-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The Stock option was granted on September 28, 2018 and vests each monthly anniversary of July 9, 2018, the vesting commencement date, over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.

SEC source: 0001628280-23-017281 · wf-form4_168375128984925.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-23-008452 · wf-form4_167908267684338.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,810

F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price.

SEC source: 0001628280-23-007372 · wf-form4_167840052346378.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,575

Underlying: Common Stock · 10,000 shares

Expires 2028-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The Stock option was granted on September 28, 2018 and vests each monthly anniversary of July 9, 2018, the vesting commencement date, over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.

SEC source: 0001628280-23-007372 · wf-form4_167840052346378.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-23-004326 · wf-form4_167701530963041.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,186

Underlying: Common Stock · 38,186 shares

Expires 2033-02-15

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2023 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

SEC source: 0001628280-23-004326 · wf-form4_167701530963041.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,114

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2023, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

SEC source: 0001628280-22-032633 · wf-form4_167226158541725.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,062

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.11 to $41.1, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-22-032633 · wf-form4_167226158541725.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,650

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.12 to $41.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-22-032322 · wf-form4_167157320361642.xml · nonDerivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,126

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.30 to $42.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-22-032322 · wf-form4_167157320361642.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,615

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $43.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-22-032322 · wf-form4_167157320361642.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,126

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.31 to $41.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 658 shares acquired on September 14, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.

SEC source: 0001628280-22-014567 · wf-form4_165273774513923.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,468

F1 · shares: Consists of shares acquired under the PROCEPT BioRobotics 2021 Employee Stock Purchase Plan on May 13, 2022.

SEC source: 0001628280-22-008265 · wf-form4_164910714769474.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,890

Underlying: Common Stock · 6,890 shares

Expires 2032-03-30

F2 · price: The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

F2 · derivative.exercise_date: The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

SEC source: 0001628280-22-008265 · wf-form4_164910714769474.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,468

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001138723-18-000017 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,924

F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-18-000034 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,697

F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-18-000014 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,483

F1 · shares: Shares were automatically sold into the open market in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-17-000068 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,068

F1 · shares: Shares were automatically sold into the open market in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-17-000046 · edgardoc.xml · nonDerivative · entry 2

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,234

F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-17-000046 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,642

F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-17-000036 · edgardoc.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,500

Underlying: Common Stock · 72,500 shares

Expires 2027-09-29

F2 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.

SEC source: 0001138723-17-000036 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,525

F1 · shares: The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversary of the vesting commencement date over the remaining three years.

SEC source: 0001138723-17-000028 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,525

F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.

SEC source: 0001138723-17-000022 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,477

F1 · shares: Represents shares of Common Stock that were withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of RSUs.

SEC source: 0001138723-17-000004 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,779

SEC source: 0001138723-16-000142 · edgardoc.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,900

Underlying: Common Stock · 53,900 shares

Expires 2026-11-30

F2 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.

SEC source: 0001138723-16-000142 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,623

F1 · shares: The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversary of the vesting commencement date over the remaining three years.

SEC source: 0001138723-16-000122 · edgardoc.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · SVP, General Counsel &

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,023

F1 · price: A total of 6,753 shares were sold at $4.85 per share to cover tax liability of RSU release pursuant to a 10b5-1 Plan.